Table 4.
Exemestane |
Tamoxifen |
|||||
Na | Normal ET at 24 months, n (%) | Abnormal ET (≥5 mm) at 24 months, n (%) | N | Normal ET at 24 months, n (%) | Abnormal ET (≥5 mm) at 24 months, n (%) | |
Normal ET at baseline | 23 | 19 (83) | 4 (17) | 23 | 15 (65) | 8 (35) |
ET (≥5 mm) at baseline | 38 | 20 (53) | 18 (47) | 32 | 6 (19) | 26 (81) |
Baseline TVUS unavailable for one patient.
ET, endometrial thickness; TVUS, transvaginal ultrasound.